Roberta Bortolozzi

Padova, 35127, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.

NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.

Journal: Redox biology

Published: July 29, 2026

A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerability.

A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerability.

Journal: Neuro-oncology

Published: December 03, 2025

Microwave-Enhanced Synthesis of 2-Styrylquinoline-4-Carboxamides With Promising Anti-Lymphoma Activity.

Microwave-Enhanced Synthesis of 2-Styrylquinoline-4-Carboxamides With Promising Anti-Lymphoma Activity.

Journal: Archiv der Pharmazie

Published: July 31, 2025

TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells.

TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells.

Journal: Acta neuropathologica communications

Published: June 13, 2025

Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors.

Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors.

Journal: Anti-cancer agents in medicinal chemistry

Published: December 26, 2024

A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer Cells.

A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer Cells.

Journal: International journal of molecular sciences

Published: December 06, 2023

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: October 18, 2023

Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma.

Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma.

Journal: Acta neuropathologica communications

Published: August 03, 2023

Surviving the hunger games: Metabolic reprogramming in medulloblastoma.

Surviving the hunger games: Metabolic reprogramming in medulloblastoma.

Journal: Biochemical pharmacology

Published: May 17, 2023

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.

Journal: European journal of medicinal chemistry

Published: February 01, 2023

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers.

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers.

Journal: Haematologica

Published: December 31, 2022

Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.

Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 28, 2022

Showing 1-12 of 67

Last Updated: 09/26/2026